Huiwei Sun
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 10
- CAR-T cell therapy research 4
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Qiyu Jiang (17 shared papers)Fan Feng (12 shared papers)Yantao Chai (15 shared papers)Xiaojuan Li (8 shared papers)Yingshi Zhang (5 shared papers)Ruichuang Yang (5 shared papers)Yu Cao (3 shared papers)Yongping Yang (3 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (3 papers)Frontiers in Pharmacology (3 papers)Pharmacological Research (3 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Huiwei Sun
24 papers receiving 769 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 280
- Hepatology 127
- Oncology 249
- Pathology and Forensic Medicine 114
- Molecular Biology 388
Countries citing papers authored by Huiwei Sun
This map shows the geographic impact of Huiwei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiwei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiwei Sun more than expected).
Fields of papers citing papers by Huiwei Sun
This network shows the impact of papers produced by Huiwei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiwei Sun. The network helps show where Huiwei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Huiwei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 102 | |
| 2 | 2018 | 93 | |
| 3 | 2018 | 90 | |
| 4 | 2018 | 73 | |
| 5 | 2018 | 56 | |
| 6 | 2020 | 52 | |
| 7 | 2019 | 47 | |
| 8 | 2015 | 40 | |
| 9 | 2015 | 32 | |
| 10 | 2023 | 29 | |
| 11 | 2013 | 26 | |
| 12 | 2021 | 24 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2019 | 19 | |
| 16 | 2012 | 15 | |
| 17 | 2012 | 14 | |
| 18 | 2021 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 6 |
About Huiwei Sun
Huiwei Sun is a scholar working on Oncology, Molecular Biology, Cancer Research, Hepatology and Pathology and Forensic Medicine, having authored 24 papers that have together received 783 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), CAR-T cell therapy research (4 papers), Cancer Mechanisms and Therapy (4 papers), MicroRNA in disease regulation (3 papers), Cancer, Lipids, and Metabolism (3 papers), Virus-based gene therapy research (2 papers), Liver physiology and pathology (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (280 citations), Hepatology (127 citations), Oncology (249 citations), Pathology and Forensic Medicine (114 citations) and Molecular Biology (388 citations). Huiwei Sun has collaborated with scholars based in China and United States. Frequent co-authors include Qiyu Jiang, Fan Feng, Yantao Chai, Xiaojuan Li, Yingshi Zhang, Ruichuang Yang, Yu Cao, Yongping Yang, Boan Li and Hui Jia. Their work appears in journals such as Frontiers in Oncology, Biochimica et Biophysica Acta (BBA) - General Subjects, Frontiers in Pharmacology, Pharmacological Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.